Byline Bancorp (NYSE:BY) reported quarterly earnings of $0.65 per share which beat the analyst consensus estimate of $0.59 by 10.17 percent. This is a 5.8 percent decrease over earnings of $0.69 per share from the same period last year.
Akebia Announces UK MHRA Approval Of Vafseo For The Treatment Of Symptomatic Anemia Associated With Chronic Kidney Disease In Adults On Chronic Maintenance Dialysis
Akebia Therapeutics®, Inc. (NASDAQ:AKBA) today announced that the United Kingdom (UK) Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for Vafseo® (vadadustat), an